Baxter International Inc. disclosed in its latest quarterly report
on Form 10-Q filed with the U.S. Securities and Exchange
Commission the next trial in Propofol litigation is scheduled for
August 2011.
The company is a defendant, along with others, in numerous…
provides in-depth news coverage of pending and recently settled lawsuits involving public companies with assets of USD $1 billion or more. Covered litigation topics include tax issues, insurance disputes, labor problems, shareholder suits, antitrust suits, product liability suits, toxic torts, personal injury suits, among others.